Two Sigma Investments, LP Bristol Myers Squibb CO Transaction History
Two Sigma Investments, LP
- $59 Billion
- Q3 2025
A detailed history of Two Sigma Investments, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Two Sigma Investments, LP holds 5,453,357 shares of BMY stock, worth $255 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
5,453,357
Previous 864,756
530.62%
Holding current value
$255 Million
Previous $40 Million
514.42%
% of portfolio
0.42%
Previous 0.08%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...